loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol

Menu
$ API Ref.Price (USD/KG) : 17,014Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ADAMIS PHARMS CORP

02 1ARMSTRONG PHARMS

03 7ARS PHARMS OPERATION

04 5BPI LABS

05 20ENDO OPERATIONS

06 49KALEO INC

07 10MYLAN SPECIALITY LP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 11141540

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207534

Patent Use Code : U-3379

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-10-20

blank

02

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 11141540

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 207534

Patent Use Code : U-3379

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-10-20

blank

03

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 8367734

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205920

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-26

blank

04

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 9283197

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205029

Patent Use Code : U-1829

Delist Requested : Y

Patent Use Description : EMERGENCY TREATMENT OF...

Patent Expiration Date : 2034-08-15

blank

05

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 10039728

Drug Substance Claim :

Drug Product Claim :

Application Number : 205029

Patent Use Code : U-1828

Delist Requested : Y

Patent Use Description : INCREASING MEAN ARTERI...

Patent Expiration Date : 2034-08-14

blank

06

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 9283197

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205029

Patent Use Code : U-1828

Delist Requested : Y

Patent Use Description : INCREASING MEAN ARTERI...

Patent Expiration Date : 2034-08-15

blank

07

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 10004700

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205029

Patent Use Code : U-2325

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2034-08-14

blank

08

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 9283197

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205029

Patent Use Code : U-1830

Delist Requested : Y

Patent Use Description : INDUCTION AND MAINTENA...

Patent Expiration Date : 2034-08-15

blank

09

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 9833573

Drug Substance Claim :

Drug Product Claim :

Application Number : 201739

Patent Use Code : U-2172

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-11-23

blank

10

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EPINEPHRINE

US Patent Number : 10688244

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201739

Patent Use Code : U-2980

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-21

blank